These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28546095)

  • 21. Trends in the use of puberty blockers among transgender children in the United States.
    Lopez CM; Solomon D; Boulware SD; Christison-Lagay ER
    J Pediatr Endocrinol Metab; 2018 Jun; 31(6):665-670. PubMed ID: 29715194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Puberty is not a disorder.
    Trumbull D; Cretella MA; Grossman M
    Pediatrics; 2015 May; 135(5):e1366. PubMed ID: 25934901
    [No Abstract]   [Full Text] [Related]  

  • 23. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
    Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
    J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for pubertal suspension and gender reassignment for transgender adolescents.
    Hembree WC
    Child Adolesc Psychiatr Clin N Am; 2011 Oct; 20(4):725-32. PubMed ID: 22051008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insurance Coverage of Puberty Blocker Therapies for Transgender Youth.
    Stevens J; Gomez-Lobo V; Pine-Twaddell E
    Pediatrics; 2015 Dec; 136(6):1029-31. PubMed ID: 26527547
    [No Abstract]   [Full Text] [Related]  

  • 26. Ensuring Gender-Affirming Care in Nephrology: Improving Care for Transgender and Gender-Expansive Individuals.
    Mohottige D; Lunn MR
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1195-1197. PubMed ID: 32139362
    [No Abstract]   [Full Text] [Related]  

  • 27. How young is too young: ethical concerns in genital surgery of the transgender MTF adolescent.
    Milrod C
    J Sex Med; 2014 Feb; 11(2):338-46. PubMed ID: 24238576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation.
    Turban JL; King D; Carswell JM; Keuroghlian AS
    Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31974216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serving transgender people: clinical care considerations and service delivery models in transgender health.
    Wylie K; Knudson G; Khan SI; Bonierbale M; Watanyusakul S; Baral S
    Lancet; 2016 Jul; 388(10042):401-411. PubMed ID: 27323926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy.
    Shumer DE; Spack NP
    Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):69-73. PubMed ID: 23221495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatrics: Transgender medicine--long-term outcomes from 'the Dutch model'.
    Shumer DE; Spack NP
    Nat Rev Urol; 2015 Jan; 12(1):12-3. PubMed ID: 25403246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of Puberty Suppression and Surgical Options for Transgender Youth.
    van de Grift TC; van Gelder ZJ; Mullender MG; Steensma TD; de Vries ALC; Bouman MB
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33106340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria.
    Costa R; Dunsford M; Skagerberg E; Holt V; Carmichael P; Colizzi M
    J Sex Med; 2015 Nov; 12(11):2206-14. PubMed ID: 26556015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sexual Experiences of Young Transgender Persons During and After Gender-Affirmative Treatment.
    Bungener SL; de Vries ALC; Popma A; Steensma TD
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 33257402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature.
    Rew L; Young CC; Monge M; Bogucka R
    Child Adolesc Ment Health; 2021 Feb; 26(1):3-14. PubMed ID: 33320999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foreword.
    Curr Probl Cardiol; 2020 May; 45(5):100559. PubMed ID: 32192631
    [No Abstract]   [Full Text] [Related]  

  • 37. [Puberty-delaying hormone therapy in adolescents with gender identity disorder].
    Nakatsuka M
    Seishin Shinkeigaku Zasshi; 2013; 115(3):316-22. PubMed ID: 23691819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing gender: The medical treatment of transgender young people.
    Castañeda C
    Soc Sci Med; 2015 Oct; 143():262-70. PubMed ID: 25641206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
    Matsumoto Y
    Seishin Shinkeigaku Zasshi; 2017; 119(1):42-51. PubMed ID: 30629867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transgender, transsexualism and gender dysphoria: current developments in diagnostics and health care].
    Nieder TO; Briken P; Richter-Appelt H
    Psychother Psychosom Med Psychol; 2014 Jun; 64(6):232-45. PubMed ID: 24892869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.